Treating MASH in 2026: Guideline-Directed Care and Emerging Therapeutic Strategies

Program Description

The treatment landscape for metabolic dysfunction-associated steatohepatitis (MASH) is evolving rapidly as the need to slow fibrosis progression and improve long-term outcomes becomes increasingly urgent. While lifestyle and cardiometabolic management remain foundational, newer and emerging pharmacologic options are expanding opportunities to individualize care. Pharmacists need to understand current guidelines to appropriately identify and stage patients, recognize which therapeutic targets are being addressed, and track where therapies are in development to anticipate how practice may change. Key challenges include translating clinical trial end points and eligibility criteria into real-world patient selection and balancing efficacy with adverse event profiles and monitoring requirements. This webinar will equip pharmacists to apply MASH treatment guidelines and deepen knowledge of approved therapies, evaluating late-stage agents and interpreting trial outcomes to translate evidence into real-world patient care. This symposium is the second in the MASLD/MASH curriculum.

Target audience: Specialty and health-system pharmacist
Type of activity: Application
Release date: May 31, 2026
Expiration date: May 31, 2027
Learner level: Foundational
Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Examine the efficacy and safety of currently available therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH)
• Apply current treatment and management guidelines to develop patient-centered care plans for individuals with MASH based on disease stage and comorbidities
• Interpret emerging clinical trial data and therapeutic targets to assess the role of pipeline agents within the evolving MASH treatment landscape

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number 0290-0000-26-165-H01-P. The activity is available for CE credit through May 31, 2027.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with ineligible companies to disclose:

Faculty

Kristen Knoph, PharmD, BCPS

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Rose Buszka, PharmD, BCPS, CHCP; Susan Pordon; Brianna Winters; and Chloe Taccetta

Any relevant financial relationships listed for these individuals have been mitigated.

At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.

Educational Disclaimer

CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms